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Mycotic aneurysms are a rare cause of intracranial aneurysms that develop in the presence of infections such as infective
endocarditis. They account for a small percentage of all intracranial aneurysms and carry a high-mortality rate when ruptured.
The authors report a case of a 54-year-old man who presented with infective endocarditis of the mitral valve and acute stroke. He
subsequently developed subarachnoid hemorrhage during antibiotic treatment, and a large intracranial aneurysm was discovered
on CT Angiography. His lesion quickly progressed into an intraparenchymal hemorrhage, requiring emergent craniotomy
and aneurysm clipping. Current recommendations on the management of intracranial Mycotic Aneurysms are based on few
retrospective case studies. The natural history of the patient’s ruptured aneurysm is presented, as well as a literature review on
the management and available treatment modalities.
1.Introduction
Mycoticaneurysms (MAs),also known asinfectiveor micro-
bial aneurysms, are rare inﬂammatory neurovascular lesions
that account for 0.7–6.5% of all intracranial aneurysms [1].
MAs are unique in their natural history and pathologic
ﬁndings, with distinct angiographic features, and frequently
develop at terminal arterial branches. Because their spon-
taneous rupture results in subarachnoid and intracerebral
hemorrhage, they are associated with signiﬁcant morbidity
and mortality, as high as 60%–90% in earlier case studies,
and 12–32% in more recent literature reviews [1, 2]. The
followingisacasereportcoupledwithamethodicalreviewof
the presentation, diagnosis, complications, and management
of MAs.
2. Case History
A 54-year-old Caucasian male with a history of IE compli-
cated by cerebrovascular accident 15 years prior presented
to the emergency department complaining of slurred speech
for the past two days. He reported that his lower mouth felt
as though it had been “numbed by a dentist,” resulting in
subjective dysarthria. At the time of presentation, he denied
headaches,visualchanges,nausea,vomiting,ornumbnessor
weakness in the extremities.
The patient was febrile at 102.3 degrees Fahrenheit,
and his cardiovascular exam revealed a 3/6 holosystolic
murmur most prominent at the left midclavicular line with
radiation to the axilla. The neurologic exam was signiﬁcant
for left facial weakness, subtle slurring of speech, and diﬀuse
hyperreﬂexia of all four extremities. Marked clubbing of his
ﬁngers on both hands was appreciated.
The head CT showed an old left posterior cerebral
artery infarct and prominent basal ganglia calciﬁcation, but
neither active bleeding nor acute infarction. The MRI was
signiﬁcant for a small acute nonhemorrhagic infarct in the
right frontal periventricular white matter as well as scattered
punctate areas of chronic blood products (Figure 1).2 Case Reports in Medicine
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Figure 1: MRI of brain on presentation: (a) sagital view showing acute right side frontal lobe infarct marked by arrow. (b) Axial view with
same right side frontal lobe infarct marked by arrow. (c) Diﬀusion-Weighted Image of ischemic stroke in the right centrum semiovale.
The echocardiogram visualized large mobile vegetations
on the mitral valve (Figure 2). 6 of 6 blood cultures were
positive for Streptococcus viridans. Intravenous Penicillin G
and Gentamicin were started immediately, and after 5 days
of antibiotic treatment, the patient’s dysarthria and left facial
weakness improved.
Six days into antibiotic therapy, the patient complained
of a severe headache and was noticeably slow to respond.
The slurred speech and left facial weakness also returned.
A noncontrast CT head was repeated and showed acute
subarachnoid hemorrhage (Figure 3). The patient’s con-
dition deteriorated; he became obtunded and required
endotracheal intubation and mechanical ventilation.
The subsequent CT Cerebral Angiogram established a
multilobulated cerebral aneurysm at the A3 segment of the
right distal anterior cerebral artery measuring 13mm byCase Reports in Medicine 3
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Figure 2: Four chamber view echocardiogram showing large
vegetation on the MVL marked by arrow. LV-left ventricle, LA-
leftatrium,RV-rightventricle,RA-rightatrium,TV-tricuspidvalve,
MVL-mitral valve leaﬂet.
8.7mm at the coronal plane, as well as interval develop-
ment of intraventricular and intraparenchymal hemorrhage
(Figure 4).Aftertheplacementofaventriculostomycatheter,
the patient was emergently taken to the operating room
to undergo aneurysm clipping and ligation. The aneurysm
was located during dissection of the falx interhemispheric
ﬁssure. As is typical of a mycotic aneurysm, it was of
poor consistency with degenerated and friable walls. The
operation was complicated by aneurysm rupture for which
hemostasis was achieved with microcottonoids and clipping.
During the recovery period the patient was eventually able to
follow basic commands, though the extent of his intracranial
and valvular disease was severe. He ultimately required a
tracheostomy, and percutaneous gastric tube. Because of
the presence of intracranial hemorrhage and acute infarct,
replacement of his mitral and aortic valves was deferred.
The patient was transferred to a long-term nursing facility
and given followup with the cardiothoracic surgery team for
reassessment after a 6 week course of IV antibiotics.
3. Discussion
3.1. Pathogenesis. Mycotic aneurysms develop in IE when
friable cardiac vegetations give rise to septic emboli that
lodge in intracranial vessels at branching points and distal
branches. These emboli may occlude vessels, cause cerebral
infarction, or promote infection [3].
The vasa vasorum theory is the most widely accepted
mechanism of pathogenesis. It proposes that bacteria from
septic emboli escape through the vasa vasorum and cause
severe inﬂammation of the adventitia. The infection then
spreads inwardly [4–6]. The arterial pulsation against the
weakened vessel wall eventually results in aneurysm forma-
tion and enlargement. The resulting aneurysms are usually
fusiform and eccentric, without saccular characteristics, and
are more common in the anterior circulation [7].
Histologically, MAs are characterized by acute neu-
trophilic inﬁltration, along with marked intimal prolifera-
tion and internal elastic lamina destruction. The responsible
organism may be identiﬁed with appropriate staining [1].
Although a wide variety of bacteria, mycobacteria, viruses,
and fungi may cause mycotic aneurysms, Viridans Strep-
tococci and Staphylococcus aureus are the most common
etiologic organisms [1].
3.2. Clinical Presentation and Diagnosis. In a large case series
by Kannoth et al. 25 patients with infectious intracranial
aneurysms presented with initial symptoms of headache
(83%), fever (67%), vomiting (50%), ocular palsy (25%),
seizures (21%), behavioral changes (21%), hemiparesis
(21%), drowsiness (17%), and loss of consciousness (17%)
[8]. Almost half the patients met Duke’s criteria for IE
and gave a history of either rheumatic or congenital heart
disease.
A scoring system based on the presence of speciﬁc
clinical and radiographic ﬁndings has been proposed for
the diagnosis of MA. Points are given for the presence of
clinical markers, such as IE, meningitis, orbital cellulitis,
cavernous sinus thrombophlebitis, persistent fever, age less
than 45, recent lumbar puncture, and radiographic evidence
of aneurysm multiplicity, distal location, fusiform shape,
and change in size [9]. Applying this scheme to our patient
prior to CT Angiography would yield a score of 2. The
sensitivity and speciﬁcity of this value are 100% and 87.4%,
respectively.
3.3. Radiographic Imaging Modalities. Cerebral vascular
imaging is available through CT Angiogram (CTA), Mag-
netic Resonance Angiogram (MRA), and Digital Subtraction
Angiography (DSA). DSA, until recent decades, was the
gold standard in intracranial aneurysm diagnosis [10]. The
advent of Multidetector CT imaging (MDCT) has increased
the resolution of CTA, allowing for complete visualization
of the intracranial vascular tree. This imaging modality
carries a lower contrast burden and risk of permanent
neurologic deﬁcits than DSA. When compared to DSA, CTA
had a sensitivity of 90% and speciﬁcity of 86% in recent
systematic meta-analysis [11]. MRA is also an emerging
imaging modality in the diagnosis of intracranial aneurysms.
WhencomparedtoCTA,itis87%sensitiveand95%speciﬁc;
howeverforaneurysmssmallerthan3mm,itssensitivityfalls
to 38% versus 61% for CTA.
3.4. Management and Treatment. Given the relative rarity of
this disease, current recommendations regarding the man-
agement and treatment of MA have largely been restricted
to a limited number of case reports. Over the past decade,
themanagementofinfectiveintracranialaneurysmshasbeen
divided into medical, endovascular, and surgical treatment.
The medical intervention that is uniformly recommended is
long-termintravenousantibiotictherapyforatleast6weeks.
In 1984, Morawetz and Karp observed that unruptured4 Case Reports in Medicine
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Figure 3: Progression of the ruptured Mycotic Aneurysm: (a) initial subarachnoid hemorrhage after 6 days IV antibiotics. Note
interhemispheric hemorrhage. (b) Repeat noncontrast CT Brain 12 hours later, intraparenchymal hemorrhage is marked by arrow. Note
prominent basal ganglia calciﬁcations.
MAs could undergo spontaneous thrombosis, suggesting
that MAs could resolve completely with antibiotic therapy
alone [3] .I nar e v i e wo f2 0c a s e so fM A so v e rat e n -
year period by Chun in 2001, seven patients were initially
treated conservatively with IV antibiotics alone and followed
by serial angiography [12]. In this series, the aneurysms
in two patients decreased in size, one did not change,
two achieved successful thrombosis, and the remaining two
enlarged. Based on this review, the conclusion regarding
unruptured MAs is that medical management with 6 weeks
of IV antibiotic therapy is reasonable if closely followed by
serial angiography. The goal of serial angiography would
be to demonstrate improvement in aneurysm size and
resolution.Zhaoetal.reportedacaseinwhichaMAfailedto
show radiographic decrease in size after 2 weeks of medical
therapy, and was successfully treated with endovascular
therapy [13].
Endovascular therapy has rapidly evolved in its eﬃcacy
andabilitytoaccessmoredistalaneurysms.Thesafetyproﬁle
of this intervention is diﬃc u l tt oi n t e r p r e t ,a si ti sb a s e d
only on anecdotal and case-report data. A meta-analysis
was performed on 16 patients in previously published casesCase Reports in Medicine 5
kVP: 120
mA: 250
msec: 500
mAs: 125
ThK: 0.5mm
Aquilion
Orient: −7◦.0◦. −4◦
Page: 118 of 157
Vitrea
W/L: 131/187
Segmented
IM: 6
Z: 1
L R
I
S
RACA LACA
LMCA RMCA
LIC RIC
(a)
kVP: 120
mA: 250
msec: 500
mAs: 125
ThK: 0.5mm
Aquilion
P a g e :1 2o f1 8
Segmented
W/L: 174/209
IM:
Vitrea
LR
I
S
(b)
Vitrea
Segmented
W/L: 174/209
IM: I
S
P A
(c)
LACUSCMC CT3
CT UNLISTED PRO
,CE,Axial,2,,,
06/27/2009 1:16:01PM
R01VKH1-1
OMNIPAQUE
LOC: 54
THK: 2.0
HFS
Z: 1
C: 40
W: 450
DFOV: 20.2 ×20.2cm
Compressed 8:1
IM: 28 SE: 3
RD: 202.50
RD: 202.5
Tilt: 0.0
mA: 250
Acg no: 5
P a g e :2 8o f1 5 7
L R
P
A
cm
(d)
Ref: Unknown unknown
CT
Eval for\mycotic\anuerysm
, CE, Vol. 0.5, Vol.,,
P
Sagittal 2.45mm
IM: 12
cm 1
kVP: 120
mA: 250
msec: 500
mAs: 125
Thk: 0.5mm
P a g e :1 3o f1 4
I
S
A
Vitrea
MIP
W/L: 600/150
Aquilion
(e)
Figure 4:CTCerebralangiogramshowingalargefusiformaneurysmatthedistalanteriorcerebralartery(ACA).(a)ShadedSurfaceDisplay
CT coronal view showing a large fusiform aneurysm at the distal segment of the ACA marked by the large arrow. Proximal ACA segments
are marked by the smaller arrows. RIC: right internal carotid artery, LIC: left internal carotid artery, RMCA: right middle cerebral artery,
LMCA-left middle cerebral artery, RACA and LACA are right and left anterior cerebral arteries, respectively. (b) Close-up coronal view of
ACA mycotic aneurysm. (c) Additional sagital view of mycotic aneurysm. (d) CT Angiogram axial view, an arrow marks the location of the
ruptured aneurysm adjacent to a large hemorrhagic lesion. (e) CT Angiogram sagital view demonstrating areas of intracerebral hemorrhage.6 Case Reports in Medicine
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Figure 5: One week postoperative CT imaging demonstrating a
metallic clip in the ACA, and a ventriculostomy in the lateral
ventricle.
who underwent endovascular treatment; 69% had a good
outcome, while none had procedural-related complications
[12]. However, parent artery sacriﬁce was much more
common in patients who underwent endovascular treatment
versus open craniotomy with surgical ligation. This aﬀects
the management of diseased vessels supplying eloquent
brain parenchyma, such as areas that involve language,
sensorimotor cortex, visual cortex, hypothalamus, thalamus,
cerebral peduncles, and brain stem.
In a retrospective review performed on 14 patients with
intracranial MAs who underwent endovascular intervention
atbetween1991and1999atamajorFrenchhospital[14],no
deaths or complications were reported, 11 of the 14 patients
showed stable lesions on followup angiography 6–24 months
after endovascular embolization, and 9 had complete resolu-
tion of their presenting neurologic deﬁcit [14]. Endovascular
therapy is potentially safer and more eﬀective than open
craniotomyifperformedatahighvolumetertiarycenterand
in the absence of increased ICP, mass eﬀect, hypotension,
hematoma, or involvement of eloquent territory.
Surgical therapy with open craniotomy and aneurysm
clipping is reserved for patients with intraparenchymal
hemorrhage, or for those who require clot evacuation
and emergent reversal of increasing intracranial pressure.
Another distinct advantage of surgical intervention is the
optionofvascularbypasstopreservedistalbloodﬂow,which
is a vital consideration when the aneurysm involves eloquent
territory.
3.5. Valvular Repair in the Setting of Intracranial Septic
Emboli. The purpose of cardiac surgery is to remove the
sourceofcerebralemboliandtoimprovehemodynamics[3].
Whether the aneurysm has ruptured inﬂuences the timing
and sequence of cardiothoracic and neurosurgery [1].
Cardiac surgery is relatively safe if the MA is unruptured.
Cardiopulmonary bypass, even with its requirement for
heparinization, does not impose additional risks of rupture
perioperatively [15]. In the absence of a hemorrhagic infarct,
valve replacement can be performed with very little risk of
perioperative stroke [16]. However, if the MA has ruptured
and there is mass eﬀect from an intracerebral hematoma or
abscess, the intracranial aneurysm should be repaired ﬁrst
[3].Inthepresenceofcerebralinfarction,thedangerofhem-
orrhagic transformation warrants a 2-3 week postponement
of cardiac surgery [1]. The exception to this rule would be
if left heart failure were to develop as a consequence to IE.
T h ep r e s e n c eo fl e f th e a rtf a i l u r ew o u l dc o m p r o m i s ec e r e b r a l
perfusion, thus negating the beneﬁts of any prior interven-
tions performed on an intracranial MA. Hashimoto et al.
reported a case in which a 24-year-old female with mitral
valve IE and ruptured intracranial MA, safely underwent
urgent mechanical mitral valve replacement for worsening
congestive heart failure 10 days after suﬀering from an
intracerebralhemorrhage.NeithertheIEnorMArecurredin
the postoperative 4 year followup period [17]. Shiraishi et al.
reported a similar case in a 55 year old patient who presented
with ruptured MA and left heart failure from aortic valve IE.
In this case the patient underwent emergent bioprosthetic
aortic valve replacement and did well with resolution of MA
9 months postoperatively [18].
3.6. Prognosis and Outcome. The general consensus in the
currentliteratureisthatrupturedMAscarryaworseprogno-
sis than unruptured MAs; however, the rarity of intracranial
MAs makes it diﬃcult to ascertain prognostic markers that
may help predict likely outcomes. A comprehensive review
of 27 clinical series and 287 patients with intracranial MA
diagnosed between 1950–2009 was recently conducted by
Ducruet et al. The analysis, while limited due to hetero-
geneity of presentations and variable followup duration,
concluded that in all treatment modalities combined, 62% of
patientshadapositiveoutcome,20%facedfurtherneurolog-
ical decline, 5%died beforean invasive intervention couldbe
performed, and 12% died immediately after an intervention
was performed whether surgical or endovascular [19].
4. Summary
In the case of our patient, the diagnosis of an acute stroke
was made early in the hospital course but a MA was not
consideredinthediﬀerentialuntilafterthepatienthadasub-
arachnoid hemorrhage. MA can be prevented from rupture
when they are suspected and treated early. This case empha-
sizestheimportanceofconsideringthepresenceofMAinthe
diﬀerential diagnosis in the setting of suspected endocarditis
and focal neurological deﬁcits. If this constellation is present,
MA should be investigated with CT Angiography. Frequent
evaluations of neurological status should be performed, and
a low threshold of suspicion for subarachnoid hemorrhage
should be maintained. Finally, a neurosurgical consultCase Reports in Medicine 7
should be obtained to determine the appropriate therapeutic
intervention once the diagnosis has been made.
Medical management should be reserved for patients
withaneurysmsthathavenotyetrupturedandshouldbefol-
lowed closely with serial cerebral angiograms. Endovascular
intervention should be based on the stability of the patient
and involvement of eloquent territory. Surgical treatment
should be performed emergently in the setting of intra-
parenchymal hemorrhage or increased intracranial pressure.
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